You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

RIZATRIPTAN BENZOATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Rizatriptan Benzoate patents expire, and what generic alternatives are available?

Rizatriptan Benzoate is a drug marketed by Apotex Inc, Aurobindo Pharma Ltd, Glenmark Pharms Ltd, Jubilant Generics, Macleods Pharms Ltd, Mylan Pharms Inc, Natco Pharma Ltd, Panacea, Sandoz, Unichem, Alkem Labs Ltd, Avet Lifesciences, Chartwell Rx, Creekwood Pharms, Glenmark Generics, Invagen Pharms, and Teva Pharms. and is included in twenty-five NDAs.

The generic ingredient in RIZATRIPTAN BENZOATE is rizatriptan benzoate. There are twenty-two drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the rizatriptan benzoate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Rizatriptan Benzoate

A generic version of RIZATRIPTAN BENZOATE was approved as rizatriptan benzoate by AUROBINDO PHARMA LTD on December 31st, 2012.

  Try a Trial

Drug patent expirations by year for RIZATRIPTAN BENZOATE
Drug Prices for RIZATRIPTAN BENZOATE

See drug prices for RIZATRIPTAN BENZOATE

Drug Sales Revenue Trends for RIZATRIPTAN BENZOATE

See drug sales revenues for RIZATRIPTAN BENZOATE

Recent Clinical Trials for RIZATRIPTAN BENZOATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Merck Sharp & Dohme Corp.Phase 3

See all RIZATRIPTAN BENZOATE clinical trials

Pharmacology for RIZATRIPTAN BENZOATE
Anatomical Therapeutic Chemical (ATC) Classes for RIZATRIPTAN BENZOATE
Paragraph IV (Patent) Challenges for RIZATRIPTAN BENZOATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
MAXALT-MLT Orally Disintegrating Tablets rizatriptan benzoate 5 mg and 10 mg 020865 1 2006-02-17
MAXALT Tablets rizatriptan benzoate 5 mg and 10 mg 020864 1 2004-09-02

US Patents and Regulatory Information for RIZATRIPTAN BENZOATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET;ORAL 201993-001 Dec 31, 2012 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Creekwood Pharms RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET;ORAL 202047-002 Dec 31, 2012 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Unichem RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET;ORAL 207836-001 Mar 7, 2017 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sandoz RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET;ORAL 079230-001 Dec 31, 2012 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Unichem RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET;ORAL 207836-002 Mar 7, 2017 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.